FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

1173992002: Doxofylline (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Oct 2021. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
4639084010 Doxofylline en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
4639085011 Doxophylline en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
4639086012 Doxofylline (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Doxofylline Is a Methyl xanthine true Inferred relationship Some
Doxofylline Is a Bronchodilator (substance) true Inferred relationship Some
Doxofylline Is a Phosphodiesterase inhibitor true Inferred relationship Some
Doxofylline Is a Enzyme inhibitor false Inferred relationship Some
Doxofylline Is a Substance with adenosine receptor antagonist mechanism of action (substance) true Inferred relationship Some
Doxofylline This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Phosphodiesterase inhibitor (disposition) true Inferred relationship Some
Doxofylline This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Adenosine receptor antagonist (disposition) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing only doxofylline (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Doxofylline Inferred relationship Some 1
Doxofylline-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Doxofylline Inferred relationship Some 1
Doxofylline-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Doxofylline Inferred relationship Some 1
Product containing only doxofylline in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Doxofylline Inferred relationship Some 1
Product containing precisely doxofylline 400 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Doxofylline Inferred relationship Some 1
Product containing precisely doxofylline 400 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Doxofylline Inferred relationship Some 1

Reference Sets

GB English

US English

Back to Start